Trikafta/Kaftrio continues to be a game-changer for cystic fibrosis patients

 Vertex Pharmaceuticals’ Trikafta/Kaftrio is currently the world’s first triple-combination cystic fibrosis therapy.

Kaftrio Informatie Pagina | Mucomedia®  Blog